The studies to be carried out will concern the pathobiology of bone marrow suppression in AIDS or AIDS-related complex. The applicant intends to approach this problem in three ways. The first will utilize fresh marrow from HIV-infected individuals to determine whether injury to the megakaryocyte (MK) and the myeloid lineages, is due to immune complexes, inhibitory factors related to infection or the virus itself. Inhibitory substances will be tested in vitro on colonies from normal marrows. A direct effect of HIV will be explored by subcellular localization of HIV components immunohistochemically and by in situ hybridization with nucleic acid probes on the EM level. If cells prove to be infected, the route of entry, e.g. whether via CD4, Fc receptors or emperipolesis will be studied by analysis of normal marrow incubated with HIV for varying time periods. The second approach, to be executed in collaboration with Drl Malcolm Moore, will establish whether HIv can infect pluripotent stem cells. These will be selected with My-10 MoAB after ablation of proliferating progenitors with 4-hybroperoxycyclophosphamide, by FACS sorting or in SCID mice. Such cells are recognized by their requirement of SCF plus IL-1 for proliferation. IF pluripotent cells cannot be infected with HIV this precursor compartment could be amplified in vivo in the hope of outpacing the suppressive effect of HIV or chemotherapeutic agents such as AZT or ddI. Moreover, an argument for the clinical use of IL-1, in addition to CSF, would be provided. SImilar studies will be conducted on marrow stromal cells which elaborate the growth factors. Whether AIDS stromal cells are functionally intact will concern the structure of the virus itself and its interaction with plasma membranes. These studies will employ freeze-fracture to determine which structural components (e.g. """"""""knobs"""""""", envelopes) are responsible for various antigenic epitopes and whether insertion of HIV polypeptides affects the number and/or distribution of intrinsic membrane proteins represented by intramembranous particles (IMP). Cells cultured with HIV for 2,4,8 and 24 hrs. will also be subjected to """"""""label fracture"""""""" which permits identification of antigens on the external membrane leaflet coincident with the IMP. Redistribution of integral membrane proteins could elucidate the lytic and fusogenic phenomena exhibited by infected cells and perhaps lead to rational intervention at this level.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
1R01HL042103-01A2
Application #
3360130
Study Section
Special Emphasis Panel (ARR (V1))
Project Start
1990-07-01
Project End
1995-06-30
Budget Start
1990-07-01
Budget End
1991-06-30
Support Year
1
Fiscal Year
1990
Total Cost
Indirect Cost
Name
New York University
Department
Type
Schools of Medicine
DUNS #
004514360
City
New York
State
NY
Country
United States
Zip Code
10012
Zucker-Franklin, D; Fraig, M; Grusky, G (1995) Interaction of human immunodeficiency virus type 1, human T-cell leukemia/lymphoma virus type I (HTLV-I), and HTLV-II with in vitro-generated dendritic cells. Clin Diagn Lab Immunol 2:343-8
Shivdasani, R A; Rosenblatt, M F; Zucker-Franklin, D et al. (1995) Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin/MGDF in megakaryocyte development. Cell 81:695-704
Pancake, B A; Zucker-Franklin, D; Coutavas, E E (1995) The cutaneous T cell lymphoma, mycosis fungoides, is a human T cell lymphotropic virus-associated disease. A study of 50 patients. J Clin Invest 95:547-54
Zucker-Franklin, D; Pancake, B A; Friedman-Kien, A E (1994) Cutaneous disease resembling mycosis fungoides in HIV-infected patients whose skin and blood cells also harbor proviral HTLV type I. AIDS Res Hum Retroviruses 10:1173-7
Zucker-Franklin, D; Pancake, B A (1994) The role of human T-cell lymphotropic viruses (HTLV-I and II) in cutaneous T-cell lymphomas. Semin Dermatol 13:160-5
Zucker-Franklin, D (1994) The effect of viral infections on platelets and megakaryocytes. Semin Hematol 31:329-37
Zucker-Franklin, D; Huang, Y Q; Grusky, G E et al. (1993) Kaposi's sarcoma in a human immunodeficiency virus-negative patient with asymptomatic human T lymphotropic virus type I infection. J Infect Dis 167:987-9
Zucker-Franklin, D; Hooper, W C; Evatt, B L (1992) Human lymphotropic retroviruses associated with mycosis fungoides: evidence that human T-cell lymphotropic virus type II (HTLV-II) as well as HTLV-I may play a role in the disease. Blood 80:1537-45
Zucker-Franklin, D; Yang, J S; Grusky, G (1992) Characterization of glycoprotein IIb/IIIa-positive cells in human umbilical cord blood: their potential usefulness as megakaryocyte progenitors. Blood 79:347-55
Zheng, Z Y; Zucker-Franklin, D (1992) Apparent ineffectiveness of natural killer cells vis-a-vis retrovirus-infected targets. J Immunol 148:3679-85

Showing the most recent 10 out of 11 publications